img

Global Asthma & COPD Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Asthma & COPD Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway.
Asthma is usually considered a separate respiratory disease, but sometimes it’s mistaken for COPD. The two have similar symptoms. These symptoms include chronic coughing, wheezing, and shortness of breath.
Asthma & COPD report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Asthma & COPD market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Private Clinics are the major drivers for the industry.
Currently, North America leads the global market for asthma & COPD drugs and devices. North America was followed by Europe in terms of market capitalization. However, North America and Europe is expected to lose out some of the market share to other emerging regional markets owing to the expiry of several patens of pharmaceutical companies operating in these regions. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Asthma & COPD market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
Novartis
Merck
Abbott
Boehringer Ingelheim
AstraZeneca
Roche
Teva
Vectura
Pfizer
Mylan
Allergan
Cipla
Akorn
Segment by Type
Anti-inflammatory Drugs
Bronchodilator Monotherapy
Combination Drugs

Segment by Application


Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Asthma & COPD market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Asthma & COPD, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Asthma & COPD industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Asthma & COPD in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Asthma & COPD introduction, etc. Asthma & COPD Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Asthma & COPD market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Asthma & COPD Market Overview
1.1 Asthma & COPD Product Overview
1.2 Asthma & COPD Market Segment by Type
1.2.1 Anti-inflammatory Drugs
1.2.2 Bronchodilator Monotherapy
1.2.3 Combination Drugs
1.3 Global Asthma & COPD Market Size by Type
1.3.1 Global Asthma & COPD Market Size Overview by Type (2018-2034)
1.3.2 Global Asthma & COPD Historic Market Size Review by Type (2018-2024)
1.3.3 Global Asthma & COPD Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Asthma & COPD Sales Breakdown by Type (2018-2024)
1.4.2 Europe Asthma & COPD Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Asthma & COPD Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Asthma & COPD Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Asthma & COPD Sales Breakdown by Type (2018-2024)
2 Global Asthma & COPD Market Competition by Company
2.1 Global Top Players by Asthma & COPD Sales (2018-2024)
2.2 Global Top Players by Asthma & COPD Revenue (2018-2024)
2.3 Global Top Players by Asthma & COPD Price (2018-2024)
2.4 Global Top Manufacturers Asthma & COPD Manufacturing Base Distribution, Sales Area, Product Type
2.5 Asthma & COPD Market Competitive Situation and Trends
2.5.1 Asthma & COPD Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Asthma & COPD Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Asthma & COPD as of 2022)
2.7 Date of Key Manufacturers Enter into Asthma & COPD Market
2.8 Key Manufacturers Asthma & COPD Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Asthma & COPD Status and Outlook by Region
3.1 Global Asthma & COPD Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Asthma & COPD Historic Market Size by Region
3.2.1 Global Asthma & COPD Sales in Volume by Region (2018-2024)
3.2.2 Global Asthma & COPD Sales in Value by Region (2018-2024)
3.2.3 Global Asthma & COPD Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Asthma & COPD Forecasted Market Size by Region
3.3.1 Global Asthma & COPD Sales in Volume by Region (2024-2034)
3.3.2 Global Asthma & COPD Sales in Value by Region (2024-2034)
3.3.3 Global Asthma & COPD Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Asthma & COPD by Application
4.1 Asthma & COPD Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Private Clinics
4.1.3 Drug Stores
4.1.4 Retail Pharmacies
4.1.5 E-Commerce
4.2 Global Asthma & COPD Market Size by Application
4.2.1 Global Asthma & COPD Market Size Overview by Application (2018-2034)
4.2.2 Global Asthma & COPD Historic Market Size Review by Application (2018-2024)
4.2.3 Global Asthma & COPD Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Asthma & COPD Sales Breakdown by Application (2018-2024)
4.3.2 Europe Asthma & COPD Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Asthma & COPD Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Asthma & COPD Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Asthma & COPD Sales Breakdown by Application (2018-2024)
5 North America Asthma & COPD by Country
5.1 North America Asthma & COPD Historic Market Size by Country
5.1.1 North America Asthma & COPD Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Asthma & COPD Sales in Volume by Country (2018-2024)
5.1.3 North America Asthma & COPD Sales in Value by Country (2018-2024)
5.2 North America Asthma & COPD Forecasted Market Size by Country
5.2.1 North America Asthma & COPD Sales in Volume by Country (2024-2034)
5.2.2 North America Asthma & COPD Sales in Value by Country (2024-2034)
6 Europe Asthma & COPD by Country
6.1 Europe Asthma & COPD Historic Market Size by Country
6.1.1 Europe Asthma & COPD Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Asthma & COPD Sales in Volume by Country (2018-2024)
6.1.3 Europe Asthma & COPD Sales in Value by Country (2018-2024)
6.2 Europe Asthma & COPD Forecasted Market Size by Country
6.2.1 Europe Asthma & COPD Sales in Volume by Country (2024-2034)
6.2.2 Europe Asthma & COPD Sales in Value by Country (2024-2034)
7 Asia-Pacific Asthma & COPD by Region
7.1 Asia-Pacific Asthma & COPD Historic Market Size by Region
7.1.1 Asia-Pacific Asthma & COPD Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Asthma & COPD Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Asthma & COPD Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Asthma & COPD Forecasted Market Size by Region
7.2.1 Asia-Pacific Asthma & COPD Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Asthma & COPD Sales in Value by Region (2024-2034)
8 Latin America Asthma & COPD by Country
8.1 Latin America Asthma & COPD Historic Market Size by Country
8.1.1 Latin America Asthma & COPD Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Asthma & COPD Sales in Volume by Country (2018-2024)
8.1.3 Latin America Asthma & COPD Sales in Value by Country (2018-2024)
8.2 Latin America Asthma & COPD Forecasted Market Size by Country
8.2.1 Latin America Asthma & COPD Sales in Volume by Country (2024-2034)
8.2.2 Latin America Asthma & COPD Sales in Value by Country (2024-2034)
9 Middle East and Africa Asthma & COPD by Country
9.1 Middle East and Africa Asthma & COPD Historic Market Size by Country
9.1.1 Middle East and Africa Asthma & COPD Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Asthma & COPD Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Asthma & COPD Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Asthma & COPD Forecasted Market Size by Country
9.2.1 Middle East and Africa Asthma & COPD Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Asthma & COPD Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GSK Asthma & COPD Products Offered
10.1.5 GSK Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novartis Asthma & COPD Products Offered
10.2.5 Novartis Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Merck Asthma & COPD Products Offered
10.3.5 Merck Recent Development
10.4 Abbott
10.4.1 Abbott Company Information
10.4.2 Abbott Introduction and Business Overview
10.4.3 Abbott Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Abbott Asthma & COPD Products Offered
10.4.5 Abbott Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Information
10.5.2 Boehringer Ingelheim Introduction and Business Overview
10.5.3 Boehringer Ingelheim Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Boehringer Ingelheim Asthma & COPD Products Offered
10.5.5 Boehringer Ingelheim Recent Development
10.6 AstraZeneca
10.6.1 AstraZeneca Company Information
10.6.2 AstraZeneca Introduction and Business Overview
10.6.3 AstraZeneca Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.6.4 AstraZeneca Asthma & COPD Products Offered
10.6.5 AstraZeneca Recent Development
10.7 Roche
10.7.1 Roche Company Information
10.7.2 Roche Introduction and Business Overview
10.7.3 Roche Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Roche Asthma & COPD Products Offered
10.7.5 Roche Recent Development
10.8 Teva
10.8.1 Teva Company Information
10.8.2 Teva Introduction and Business Overview
10.8.3 Teva Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Teva Asthma & COPD Products Offered
10.8.5 Teva Recent Development
10.9 Vectura
10.9.1 Vectura Company Information
10.9.2 Vectura Introduction and Business Overview
10.9.3 Vectura Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Vectura Asthma & COPD Products Offered
10.9.5 Vectura Recent Development
10.10 Pfizer
10.10.1 Pfizer Company Information
10.10.2 Pfizer Introduction and Business Overview
10.10.3 Pfizer Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Pfizer Asthma & COPD Products Offered
10.10.5 Pfizer Recent Development
10.11 Mylan
10.11.1 Mylan Company Information
10.11.2 Mylan Introduction and Business Overview
10.11.3 Mylan Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Mylan Asthma & COPD Products Offered
10.11.5 Mylan Recent Development
10.12 Allergan
10.12.1 Allergan Company Information
10.12.2 Allergan Introduction and Business Overview
10.12.3 Allergan Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Allergan Asthma & COPD Products Offered
10.12.5 Allergan Recent Development
10.13 Cipla
10.13.1 Cipla Company Information
10.13.2 Cipla Introduction and Business Overview
10.13.3 Cipla Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Cipla Asthma & COPD Products Offered
10.13.5 Cipla Recent Development
10.14 Akorn
10.14.1 Akorn Company Information
10.14.2 Akorn Introduction and Business Overview
10.14.3 Akorn Asthma & COPD Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Akorn Asthma & COPD Products Offered
10.14.5 Akorn Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Asthma & COPD Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Asthma & COPD Industrial Chain Analysis
11.4 Asthma & COPD Market Dynamics
11.4.1 Asthma & COPD Industry Trends
11.4.2 Asthma & COPD Market Drivers
11.4.3 Asthma & COPD Market Challenges
11.4.4 Asthma & COPD Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Asthma & COPD Distributors
12.3 Asthma & COPD Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Anti-inflammatory Drugs
Table 2. Major Company of Bronchodilator Monotherapy
Table 3. Major Company of Combination Drugs
Table 4. Global Asthma & COPD Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Asthma & COPD Sales by Type (2018-2024) & (K Units)
Table 6. Global Asthma & COPD Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Asthma & COPD Sales by Type (2018-2024) & (US& Million)
Table 8. Global Asthma & COPD Market Share in Value by Type (2018-2024)
Table 9. Global Asthma & COPD Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Asthma & COPD Sales by Type (2024-2034) & (K Units)
Table 11. Global Asthma & COPD Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Asthma & COPD Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Asthma & COPD Sales Market Share in Value by Type (2024-2034)
Table 14. Global Asthma & COPD Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Asthma & COPD Sales by Type (2018-2024) & (K Units)
Table 16. North America Asthma & COPD Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Asthma & COPD Sales (K Units) by Type (2018-2024)
Table 18. Europe Asthma & COPD Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Asthma & COPD Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Asthma & COPD Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Asthma & COPD Sales (K Units) by Type (2018-2024)
Table 22. Latin America Asthma & COPD Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Asthma & COPD Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Asthma & COPD Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Asthma & COPD Sales by Company (2018-2024) & (K Units)
Table 26. Global Asthma & COPD Sales Share by Company (2018-2024)
Table 27. Global Asthma & COPD Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Asthma & COPD Revenue Share by Company (2018-2024)
Table 29. Global Market Asthma & COPD Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Asthma & COPD Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Asthma & COPD Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Asthma & COPD as of 2022)
Table 33. Date of Key Manufacturers Enter into Asthma & COPD Market
Table 34. Key Manufacturers Asthma & COPD Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Asthma & COPD Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Asthma & COPD Sales by Region (2018-2024) & (K Units)
Table 38. Global Asthma & COPD Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Asthma & COPD Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Asthma & COPD Sales Market Share in Value by Region (2018-2024)
Table 41. Global Asthma & COPD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Asthma & COPD Sales by Region (2024-2034) & (K Units)
Table 43. Global Asthma & COPD Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Asthma & COPD Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Asthma & COPD Sales Market Share in Value by Region (2024-2034)
Table 46. Global Asthma & COPD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Asthma & COPD Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Asthma & COPD Sales by Application (2018-2024) & (K Units)
Table 49. Global Asthma & COPD Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Asthma & COPD Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Asthma & COPD Sales Market Share in Value by Application (2018-2024)
Table 52. Global Asthma & COPD Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Asthma & COPD Sales by Application (2024-2034) & (K Units)
Table 54. Global Asthma & COPD Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Asthma & COPD Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Asthma & COPD Sales Market Share in Value by Application (2024-2034)
Table 57. Global Asthma & COPD Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Asthma & COPD Sales by Application (2018-2024) (K Units)
Table 59. North America Asthma & COPD Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Asthma & COPD Sales by Application (2018-2024) (K Units)
Table 61. Europe Asthma & COPD Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Asthma & COPD Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Asthma & COPD Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Asthma & COPD Sales by Application (2018-2024) (K Units)
Table 65. Latin America Asthma & COPD Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Asthma & COPD Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Asthma & COPD Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Asthma & COPD Sales by Country (2018-2024) & (K Units)
Table 69. North America Asthma & COPD Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Asthma & COPD Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Asthma & COPD Sales Market Share in Value by Country (2018-2024)
Table 72. North America Asthma & COPD Sales by Country (2024-2034) & (K Units)
Table 73. North America Asthma & COPD Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Asthma & COPD Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Asthma & COPD Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Asthma & COPD Sales by Country (2018-2024) & (K Units)
Table 77. Europe Asthma & COPD Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Asthma & COPD Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Asthma & COPD Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Asthma & COPD Sales by Country (2024-2034) & (K Units)
Table 81. Europe Asthma & COPD Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Asthma & COPD Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Asthma & COPD Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Asthma & COPD Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Asthma & COPD Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Asthma & COPD Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Asthma & COPD Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Asthma & COPD Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Asthma & COPD Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Asthma & COPD Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Asthma & COPD Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Asthma & COPD Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Asthma & COPD Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Asthma & COPD Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Asthma & COPD Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Asthma & COPD Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Asthma & COPD Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Asthma & COPD Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Asthma & COPD Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Asthma & COPD Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Asthma & COPD Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Asthma & COPD Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Asthma & COPD Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Asthma & COPD Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Asthma & COPD Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Asthma & COPD Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Asthma & COPD Sales Market Share in Value by Country (2024-2034)
Table 108. GSK Company Information
Table 109. GSK Introduction and Business Overview
Table 110. GSK Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. GSK Asthma & COPD Product
Table 112. GSK Recent Development
Table 113. Novartis Company Information
Table 114. Novartis Introduction and Business Overview
Table 115. Novartis Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Novartis Asthma & COPD Product
Table 117. Novartis Recent Development
Table 118. Merck Company Information
Table 119. Merck Introduction and Business Overview
Table 120. Merck Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Merck Asthma & COPD Product
Table 122. Merck Recent Development
Table 123. Abbott Company Information
Table 124. Abbott Introduction and Business Overview
Table 125. Abbott Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Abbott Asthma & COPD Product
Table 127. Abbott Recent Development
Table 128. Boehringer Ingelheim Company Information
Table 129. Boehringer Ingelheim Introduction and Business Overview
Table 130. Boehringer Ingelheim Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Boehringer Ingelheim Asthma & COPD Product
Table 132. Boehringer Ingelheim Recent Development
Table 133. AstraZeneca Company Information
Table 134. AstraZeneca Introduction and Business Overview
Table 135. AstraZeneca Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. AstraZeneca Asthma & COPD Product
Table 137. AstraZeneca Recent Development
Table 138. Roche Company Information
Table 139. Roche Introduction and Business Overview
Table 140. Roche Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Roche Asthma & COPD Product
Table 142. Roche Recent Development
Table 143. Teva Company Information
Table 144. Teva Introduction and Business Overview
Table 145. Teva Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Teva Asthma & COPD Product
Table 147. Teva Recent Development
Table 148. Vectura Company Information
Table 149. Vectura Introduction and Business Overview
Table 150. Vectura Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Vectura Asthma & COPD Product
Table 152. Vectura Recent Development
Table 153. Pfizer Company Information
Table 154. Pfizer Introduction and Business Overview
Table 155. Pfizer Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Pfizer Asthma & COPD Product
Table 157. Pfizer Recent Development
Table 158. Mylan Company Information
Table 159. Mylan Introduction and Business Overview
Table 160. Mylan Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Mylan Asthma & COPD Product
Table 162. Mylan Recent Development
Table 163. Allergan Company Information
Table 164. Allergan Introduction and Business Overview
Table 165. Allergan Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Allergan Asthma & COPD Product
Table 167. Allergan Recent Development
Table 168. Cipla Company Information
Table 169. Cipla Introduction and Business Overview
Table 170. Cipla Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Cipla Asthma & COPD Product
Table 172. Cipla Recent Development
Table 173. Akorn Company Information
Table 174. Akorn Introduction and Business Overview
Table 175. Akorn Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Akorn Asthma & COPD Product
Table 177. Akorn Recent Development
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Asthma & COPD Market Trends
Table 181. Asthma & COPD Market Drivers
Table 182. Asthma & COPD Market Challenges
Table 183. Asthma & COPD Market Restraints
Table 184. Asthma & COPD Distributors List
Table 185. Asthma & COPD Downstream Customers
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Asthma & COPD Product Picture
Figure 2. Global Asthma & COPD Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Asthma & COPD Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Asthma & COPD Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Anti-inflammatory Drugs
Figure 6. Global Anti-inflammatory Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Bronchodilator Monotherapy
Figure 8. Global Bronchodilator Monotherapy Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Combination Drugs
Figure 10. Global Combination Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Asthma & COPD Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Asthma & COPD Sales Market Share by Type in 2022 & 2034
Figure 13. North America Asthma & COPD Sales Market Share in Volume by Type in 2022
Figure 14. North America Asthma & COPD Sales Market Share in Value by Type in 2022
Figure 15. Europe Asthma & COPD Sales Market Share in Volume by Type in 2022
Figure 16. Europe Asthma & COPD Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Asthma & COPD Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Asthma & COPD Sales Market Share in Value by Type in 2022
Figure 19. Latin America Asthma & COPD Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Asthma & COPD Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Asthma & COPD Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Asthma & COPD Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Asthma & COPD Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Asthma & COPD Revenue in 2022
Figure 25. Asthma & COPD Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital Pharmacies
Figure 27. Global Hospital Pharmacies Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Private Clinics
Figure 29. Global Private Clinics Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Drug Stores
Figure 31. Global Drug Stores Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Retail Pharmacies
Figure 33. Global Retail Pharmacies Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of E-Commerce
Figure 35. Global E-Commerce Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Global Asthma & COPD Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Asthma & COPD Sales Market Share by Application in 2022 & 2034
Figure 38. North America Asthma & COPD Sales Market Share in Volume by Application in 2022
Figure 39. North America Asthma & COPD Sales Market Share in Value by Application in 2022
Figure 40. Europe Asthma & COPD Sales Market Share in Volume by Application in 2022
Figure 41. Europe Asthma & COPD Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Asthma & COPD Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Asthma & COPD Sales Market Share in Value by Application in 2022
Figure 44. Latin America Asthma & COPD Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Asthma & COPD Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Asthma & COPD Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Asthma & COPD Manufacturing Cost Structure
Figure 49. Asthma & COPD Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries